Skip to menu Skip to content Skip to footer
Associate Professor

Graeme Macdonald

Email: 
Phone: 
+61 7 3176 2613

Overview

Availability

Associate Professor Graeme Macdonald is:
Available for supervision
Media expert

Qualifications

  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Works

Search Professor Graeme Macdonald’s works on UQ eSpace

281 works between 1994 and 2025

181 - 200 of 281 works

2008

Conference Publication

What do GPS in QLD really think about community based HCV prescribing?

Martin, J., Ferndale, C., Hayllar, J., Lambert, S., McGrath, F., Page, A., Reiner, R., Reuter, B., Sexton, J., White, S., Wittmann, J. and Macdonald, G. (2008). What do GPS in QLD really think about community based HCV prescribing?. 6th Australasian Viral Hepatitis Conference, Brisbane, Queensland, Australia, 20–22 October 2008. Carlton South, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05655_2.x

What do GPS in QLD really think about community based HCV prescribing?

2008

Conference Publication

Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease

Hickman, I. J., Sullivan, C. M., Flight, S., Campbell, C., Crawford, D. H., Masci, P. P., O'Moore-Sullivan, T. M., Prins, J. B. and Macdonald, G. A. (2008). Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease. 16th European Congress on Obesity, Geneva, Switzerland, 14-17 May 2008. LONDON: NATURE PUBLISHING GROUP.

Obesity is linked with increased clot strength and impaired fibrinolysis in nonalcoholic fatty liver disease

2008

Conference Publication

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

Nguyen, T., Murphy, T. L., Lipka, G., Fletcher, L. M. and Macdonald, G. A. (2008). The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease. Australian Gastroenterology Week, Brisbane, QLD, Australia, 22-25 October 2008. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2008.05613.x

The ratio of high molecular weight (HMW) to total adiponectin correlates with insulin resistance in fatty liver disease

2008

Conference Publication

Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores

Williams, E.J., Dixon, J., Powell, L.W. and Macdonald, G.A. (2008). Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores. 43rd Annual Meeting of the European Association for the Study of the Liver, Milan, Italy, 23-27 April 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(08)60984-8

Phlebotomy is associatied with an inprovement in liver enzymes in patients with non-alcoholic fatty liver disease and increased hepatic iron stores

2007

Journal Article

Is vitamin E beneficial in chronic liver disease?

Hickman, Ingrid J. and Macdonald, Graeme A. (2007). Is vitamin E beneficial in chronic liver disease?. Hepatology, 46 (2), 288-290. doi: 10.1002/hep.21834

Is vitamin E beneficial in chronic liver disease?

2007

Journal Article

Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes

Hickman, Ingrid J., Whitehead, Jonathan P., Prins, Johannes B. and Macdonald, Graeme A. (2007). Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes. Diabetes, Obesity and Metabolism, 9 (3), 438-440. doi: 10.1111/j.1463-1326.2006.00604.x

Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes

2007

Journal Article

Erratum: Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (British Journal of Cancer (2006) 95, (853-861) DOI: 10.1038/6603325)

Cebon, J., Findlay, M., Hargreaves, C., Stockler, M., Thompson, P., Boyer, M., Roberts, S., Poon, A., Scott, A. M., Kalff, V., Garas, G., Dowling, A., Crawford, D., Ring, J., Basser, R., Strickland, A., MacDonald, G., Green, M., Nowak, A., Dickman, B., Dhillon, H. and Gebski, V. (2007). Erratum: Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (British Journal of Cancer (2006) 95, (853-861) DOI: 10.1038/6603325). British Journal of Cancer, 96 (7), 1154-1154. doi: 10.1038/sj.bjc.6603674

Erratum: Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide (British Journal of Cancer (2006) 95, (853-861) DOI: 10.1038/6603325)

2007

Journal Article

Why do we not yet have combination chemotherapy for chronic hepatitis B?

Sasadeusz, J. J., Locarnini, S. L. and Macdonald, G. (2007). Why do we not yet have combination chemotherapy for chronic hepatitis B?. Medical Journal of Australia, 186 (4), 204-206. doi: 10.5694/j.1326-5377.2007.tb00863.x

Why do we not yet have combination chemotherapy for chronic hepatitis B?

2007

Conference Publication

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study

Sharman, J. E., Holland, D., Kostner, K., Fairweather, H., Macdonald G. and Marwick T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study. Cardiac Society of Aust and NZ Annual Scientific Meeting, Christchurch, New Zealand, 9-12 August, 2007. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1016/j.hlc.2007.06.420

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise haemodynamic study

2007

Journal Article

Silencing of O-6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa

Herath, Nirmitha I., Walsh, Michael D., Kew, Michael, Smith, Jeffery L., Jass, Jeremy R., Young, Joanne, Leggett, Barbara A. and Macdonald, Graeme A. (2007). Silencing of O-6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa. Oncology Reports, 17 (4), 817-822. doi: 10.3892/or.17.4.817

Silencing of O-6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa

2007

Conference Publication

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study

Sharman, J., Holland, D., Kostner, K. M., Fairweather, H., Macdonald, G. A. and Marwick, T. H. (2007). The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study. European Society of Cardiology Annual Scientific Meeting, Vienna, Austria, 1-5 September, 2007. London ; New York: Oxford University Press.

The association between viscosity and cardiovascular risk may reflect the central systolic stress response to light activity: an exercise hemodynamic study

2007

Journal Article

Impact of diabetes on the severity of liver disease

Hickman, I.J. and Macdonald, G.A. (2007). Impact of diabetes on the severity of liver disease. The American Journal of Medicine, 120 (10), 829-834. doi: 10.1016/j.amjmed.2007.03.025

Impact of diabetes on the severity of liver disease

2006

Journal Article

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

Cebon, J., Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators, Findlay, M., Hargreaves, C., Stockler, M., Thompson, P., Boyer, M., Roberts, S., Poon, A., Scott, A. M., Kalff, V., Garas, G., Dowling, A., Crawford, D., Ring, J., Basser, R., Strickland, A., Macdonald, G., Green, M., Nowak, A., Dickman, B., Dhillon, H. and Gebski, V. (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95 (7), 853-861. doi: 10.1038/sj.bjc.6603325

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

2006

Conference Publication

Causes of raised liver enzymes in a diabetic clinic

Hickman, I. J., Russell, A. W. and Macdonald, G. A. (2006). Causes of raised liver enzymes in a diabetic clinic. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell.

Causes of raised liver enzymes in a diabetic clinic

2006

Conference Publication

The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells

Beaton, M. D., Wilkins, S. J., Frazer, D. M., Whitehead, J. P., Moffitt, J. H., Macdonald, G. A., Powell, L. W. and Anderson, G. J. (2006). The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells. Australian Gastroenterology Week, Adelaide, SA, Australia, 1–14 October 2006. Richmond, VIC, Australia: Wiley-Blackwell.

The effect of steatosis on iron homeostasis in HuH-7 hepatoma cells

2006

Journal Article

Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophrenia

Richards, A. A., Hickman, I. J., Wang, A. Y. H., Jones, A. L., Newell, F., Mowry, B. J., Whitehead, J. P., Prins, J. B. and Macdonald, G. A. (2006). Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophrenia. Journal of Clinical Psychopharmacology, 26 (3), 232-237. doi: 10.1097/01.jcp.0000218404.64619.52

Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: A potential mechanism for Olanzapine-induced insulin resistance in patients with schizophrenia

2006

Journal Article

Living with chronic hepatitis C means 'you just haven't got a normal life any more'

Conrad, S., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006). Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness, 2 (2), 121-131. doi: 10.1177/17423953060020020701

Living with chronic hepatitis C means 'you just haven't got a normal life any more'

2006

Journal Article

Adiponectin – a key adipokine in the metabolic syndrome

Whitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald , G. A. and Prins, J. B. (2006). Adiponectin – a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism, 8 (3), 264-280. doi: 10.1111/j.1463-1326.2005.00510.x

Adiponectin – a key adipokine in the metabolic syndrome

2006

Conference Publication

Serum adiponectin is increased in HFE-/- mice fed alcohol

Bridle, K. R., Murphy, T. L., Anderson, G. J., Macdonald, G. A., Crawford, D. H. G. and Fletcher, L. M. (2006). Serum adiponectin is increased in HFE-/- mice fed alcohol. Australian Gastroenterology Week 2006, Adelaide, South Australia, 11-14 October, 2006. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2006.04689.x

Serum adiponectin is increased in HFE-/- mice fed alcohol

2006

Journal Article

Review of genetic and epigenetic alterations in hepatocarcinogenesis

Herath, NI, Leggett, BA and Macdonald, GA (2006). Review of genetic and epigenetic alterations in hepatocarcinogenesis. Journal of Gastroenterology And Hepatology, 21 (1), 15-21. doi: 10.1111/j.1440-1746.2005.04043.x

Review of genetic and epigenetic alterations in hepatocarcinogenesis

Funding

Current funding

  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2020 - 2022
    Liver targeted Interleukin-22 for the treatment of non-alcoholic steatohepatitis
    NHMRC IDEAS Grants
    Open grant
  • 2018 - 2019
    IL-22-based therapy ameliorates liver steatosis
    Gastroenterological Society of Australia
    Open grant
  • 2018 - 2021
    Evaluation of a telehealth-supported hepatitis C treatment model of care for Indigenous Health Services
    Queensland Health
    Open grant
  • 2014
    Cellular metabolic respirometry and enzymatic assessment suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    The role of gut bacterial and mucosal permeability in liver injury
    PA Research Foundation
    Open grant
  • 2012 - 2014
    HFE-associated Steatohepatitis: Mechanisms and Therapies
    NHMRC Project Grant
    Open grant
  • 2009 - 2010
    New ways to improve cardiovascular function by modulating the hormone adiponectin
    National Heart Foundation of Australia
    Open grant
  • 2009 - 2012
    Pharmacodynamics in Liver Disease and in Liver Surgery
    NHMRC Project Grant
    Open grant
  • 2008 - 2012
    Obesity-related inflammation and insulin resistance in chronic liver disease: exercise and diet as treatment options
    NHMRC Project Grant
    Open grant
  • 2007 - 2010
    Clinical measures of obesity & risk of Barrett's oesophagus
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Adiponectin: linking obesity and cardiovascular disease
    Cardiovasular Lipid Research Grants Pfizer Australia
    Open grant
  • 2006 - 2008
    Adiponectin - Multimerization, Secretion and Action
    NHMRC Project Grant
    Open grant
  • 2006
    Metabolic complications of liver transplantation
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005
    The relationship betwen serum adiponectin and inflammatory state in obese adults
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2003 - 2004
    Protocol NV17317 - Peginterferon alfa-2a & Ribavirin
    Roche Products Pty Ltd
    Open grant
  • 2003 - 2005
    Human Hepatic Insulin Resistance
    NHMRC Project Grant
    Open grant
  • 2003
    NV-02B-007 A randomized, double blind trial of LdT (Telbivudine) versus Lamivudine in adults with compensated chronic hepatitis B
    Quintiles Pty Ltd
    Open grant
  • 2002
    Symptom impact for people living with haemophilia and hepatitis C
    Haemophilia Foundation Research Fund
    Open grant
  • 2001 - 2002
    Insulin sensitivity and hepatic steatosis
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2001
    Insulin sensitivity and hepatic steatosis.
    UQ Early Career Researcher
    Open grant
  • 1999 - 2000
    Regulation of basal and insulin-stimulated glucose uptake in human muscle, liver and omental and subcutaneous adipose tissues
    Wesley Merdical Research
    Open grant
  • 1999
    The assessment of candidate tumor suppressor genes in hepatocellular carcinoma
    UQ Early Career Researcher
    Open grant

Supervision

Availability

Associate Professor Graeme Macdonald is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Master Philosophy

    Assessment of muscle mass hepatic function and outcomes in patients awaiting liver transplantation

    Principal Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The clinical utility of measuring sarcopenia, myosteatosis and frailty in the nutrition assessment of patients referred for liver transplantation.

    Associate Advisor

    Other advisors: Dr Hannah Mayr, Associate Professor Ingrid Hickman

Completed supervision

Media

Enquiries

Contact Associate Professor Graeme Macdonald directly for media enquiries about:

  • Adiponectin
  • Hepatitis
  • Illness and quality of life
  • Insulin resistance
  • Liver disease
  • Metabolic syndrome
  • Quality of life and illness
  • Steatohepatitis
  • Viral hepatitis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au